AgriMetis announces publication of additional SpinoMetis™ patent applications
Aug. 6, 2018
In March 2018, Monsanto Company (now a part of Bayer AG) and AgriMetis announced an exclusive collaboration for Monsanto’s continued research with AgriMetis’ SpinoMetis platform, and the compounds exemplified in this application are included in that collaboration.
“The novel compounds described in AgriMetis’ numerous SpinoMetis-related applications show strong performance, and we look forward to working with the Bayer and Monsanto team to advance them through the development process,” said Brian Green, AgriMetis’ VP of Research and Development.
With this addition to its growing patent portfolio, AgriMetis continues to progress toward delivering commercially viable products to the agricultural crop protection industry through an extensive and expanding research and development pipeline. For more information on this PCT publication, a link is provided below:https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018132288
More from AgroNews
- Health Canada proposes banning neonicotinoid insecticides in five years
- Brazil AgrochemShow 2018: Exemption of adjuvants from registration requires legal attention
- Most Chinese listed pesticide enterprises’ semi-annual performance in 2018 predicted to grow
- QSAR (Quantitative structure-activity relationship) Models: An Increasing Trend in Toxicological Evaluations for Pesticides Registration